Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort
Autor: | Anders Tidblad, Muriel Thomas, Lars Sävendahl, Christa E. Flück, Dominique Beckers, Peter E. Clayton, Aysha J. Khan, Joël Coste, Stefano Cianfarani, Annalisa Deodati, Jean-Claude Carel, Roland Pfäffle, Sally Tollerfield, Gladys R J Zandwijken, Emmanuel Ecosse, Grit Sommer, Anita C. S. Hokken-Koelega, Gary Butler, Claudia E. Kuehni, Anthony J. Swerdlow, Rosie Cooke, Wieland Kiess |
---|---|
Přispěvatelé: | Pediatrics |
Rok vydání: | 2019 |
Předmět: |
Male
Pediatrics Endocrinology Diabetes and Metabolism Clinical Biochemistry Biochemistry 0302 clinical medicine Endocrinology Neoplasms Meningeal Neoplasms Registries Child Growth Disorders Cumulative dose Adolescent Adult Child Preschool Cranial Irradiation Europe Female Follow-Up Studies Human Growth Hormone Humans Incidence Infant Infant Newborn Meningioma Neoplasms Second Primary Recombinant Proteins Risk Assessment Young Adult Incidence (epidemiology) Settore MED/38 3. Good health Growth Growth Hormone and Growth Factors Second Primary 030220 oncology & carcinogenesis Cohort Cohort study medicine.medical_specialty 030209 endocrinology & metabolism Context (language use) 610 Medicine & health Malignancy 03 medical and health sciences 360 Social problems & social services Internal medicine medicine Preschool Clinical Research Articles business.industry Biochemistry (medical) Cancer medicine.disease Newborn business |
Zdroj: | Journal of Clinical Endocrinology and Metabolism, 104(3), 658-664. Endocrine Society Clayton, P, Khan, A & et al. 2018, ' Risk of meningioma in European patients treated with growth hormone in childhood: results from the SAGhE cohort ', The Journal of Clinical Endocrinology and Metabolism . https://doi.org/10.1210/jc.2018-01133 Swerdlow, Anthony J; Cooke, Rosie; Beckers, Dominique; Butler, Gary; Carel, Jean-Claude; Cianfarani, Stefano; Clayton, Peter; Coste, Joël; Deodati, Annalisa; Ecosse, Emmanuel; Hokken-Koelega, Anita C S; Khan, Aysha J; Kiess, Wieland; Kuehni, Claudia E; Flück Pandey, Christa Emma; Pfaffle, Roland; Sävendahl, Lars; Sommer, Grit; Thomas, Muriel; Tidblad, Anders; ... (2019). Risk of meningioma in European patients treated with growth hormone in childhood: results from the SAGhE cohort. Journal of clinical endocrinology and metabolism, 104(3), pp. 658-664. Endocrine Society 10.1210/jc.2018-01133 The Journal of Clinical Endocrinology and Metabolism |
ISSN: | 0021-972X |
Popis: | Context There has been concern that GH treatment of children might increase meningioma risk. Results of published studies have been inconsistent and limited. Objective To examine meningioma risks in relation to GH treatment. Design Cohort study with follow-up via cancer registries and other registers. Setting Population-based. Patients A cohort of 10,403 patients treated in childhood with recombinant GH in five European countries since this treatment was first used in 1984. Expected rates from national cancer registration statistics. Main Outcome Measures Risk of meningioma incidence. Results During follow-up, 38 meningiomas occurred. Meningioma risk was greatly raised in the cohort overall [standardized incidence ratio (SIR) = 75.4; 95% CI: 54.9 to 103.6], as a consequence of high risk in subjects who had received radiotherapy for underlying malignancy (SIR = 658.4; 95% CI: 460.4 to 941.7). Risk was not significantly raised in patients who did not receive radiotherapy. Risk in radiotherapy-treated patients was not significantly related to mean daily dose of GH, duration of GH treatment, or cumulative dose of GH. Conclusions Our data add to evidence of very high risk of meningioma in patients treated in childhood with GH after cranial radiotherapy, but suggest that GH may not affect radiotherapy-related risk, and that there is no material raised risk of meningioma in GH-treated patients who did not receive radiotherapy. In a five-country cohort of 10,403 patients treated with recombinant growth hormone, meningioma risk was greatly raised in relation to radiotherapy, but not apparently related to growth hormone. |
Databáze: | OpenAIRE |
Externí odkaz: |